![Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms therof](/docs/US/2024-05-07/US11976077B2/abs.jpg.600x600.jpg)
- Patent Title: Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms therof
-
Application No.: US18176651Application Date: 2023-03-01
-
Publication No.: US11976077B2Publication Date: 2024-05-07
- Inventor: Aileen L. Pangan , Henrique D. Teixeira , Mohamed-Eslam F. Mohamed , Ahmed A. Othman , Ben Klünder , Jeffrey W. Voss , Robert J. Padley , Heidi S. Camp
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agency: WOMBLE BOND DICKINSON (US) LLP
- Agent Danielle L. Herritt; Scott R. Breining
- Main IPC: C07D487/14
- IPC: C07D487/14 ; A61K9/00 ; A61K9/20 ; A61K31/4985 ; A61K47/12 ; A61K47/38
![Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms therof](/abs-image/US/2024/05/07/US11976077B2/abs.jpg.150x150.jpg)
Abstract:
The present disclosure relates to processes for preparing (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide, solid state forms thereof, and corresponding pharmaceutical compositions, methods of treatment (including treatment of rheumatoid arthritis and atopic dermatitis), kits, methods of synthesis, and products-by-process.
Public/Granted literature
Information query
